NCT06970795 2025-05-14
A Study of SYS6040 for Injection in Patients With Advanced Solid Tumors
CSPC Megalith Biopharmaceutical Co.,Ltd.
Phase 1 Recruiting
CSPC Megalith Biopharmaceutical Co.,Ltd.
MediLink Therapeutics (Suzhou) Co., Ltd.
Evopoint Biosciences Inc.